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Abstract
Meal consumption leads to an increase in sympathetic output to compensate
for hemodynamic changes and maintain blood pressure (BP). Obesity is asso-
ciated with a blunting of the sympathetic response to meal ingestion, but
interpretation of studies investigating these responses is compromised by their
failure to account for the rate of gastric emptying, which is an important
determinant of postprandial cardiovascular and sympathetic responses and, in
both health and obesity, exhibits a wide interindividual variation. We sought
to determine the effects of intraduodenal glucose infusion, bypassing gastric
emptying, on BP, heart rate (HR), and noradrenaline responses in obese and
healthy control subjects. 12 obese subjects (age 36.6  3.9 years, body mass
index (BMI) 36.1  1.3 kg/m2) and 23 controls (age 27.8  2.4 years, BMI
22.4  0.5 kg/m2) received intraduodenal infusions of glucose at 1 or 3 kcal/
min, or saline, for 60 min (t = 0–60 min), followed by intraduodenal saline
(t = 60–120 min). BP and HR were measured with an automatic cuff, and
blood samples collected for measurement of plasma noradrenaline. Intraduo-
denal glucose at 1 kcal/min was associated with a fall in diastolic BP in the
control subjects only (P < 0.01), with no change in systolic BP, HR or nora-
drenaline in either group. In both groups, intraduodenal glucose at 3 kcal/min
was associated with a fall in diastolic (P < 0.01), but not systolic, BP, and rises
in HR (P < 0.001) and plasma noradrenaline (P < 0.01), with no difference in
responses between the groups. We conclude that cardiovascular and sympa-
thetic responses to intraduodenal glucose infusion are comparable between
obese and control subjects, and dependent on the rate of glucose delivery.
Introduction
The postprandial cardiovascular response in health
involves splanchnic blood pooling compensated for by
increases in cardiac output and heart rate (HR), along
with vasoconstriction in skeletal muscle and the periph-
eral vasculature, so there is minimal change in blood
pressure (BP) (Sidery et al. 1991; Waaler and Eriksen
1992). These responses are driven by barostat activation
and autonomic pathways (Kearney et al. 1995), and in
healthy subjects, meal ingestion is associated with an
increase in sympathetic nerve activity and plasma nora-
drenaline concentrations (Fagius and Berne 1994; Fagius
et al. 1996).
Obesity is reportedly associated with a blunting of the
sympathetic response (assessed by muscle sympathetic
nerve activity (MSNA) and plasma noradrenaline) to
ingestion of oral glucose (Vollenweider et al. 1994; Straz-
nicky et al. 2009), particularly in individuals with insulin
resistance and the metabolic syndrome (Spraul et al.
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1994; Vollenweider et al. 1994; Straznicky et al. 2009). It
has been suggested that impaired postprandial sympa-
thetic responses may predispose to weight gain through a
reduction in insulin-induced vasodilation in skeletal mus-
cle (Vollenweider et al. 1994). In contrast, the fasting
sympathetic response has been reported to be elevated in
obese subjects (Fagius 2003).
Interpretation of the outcomes of studies in obese sub-
jects that have investigated the cardiovascular and sympa-
thetic responses to ingested nutrients is confounded,
because of failure to account for the rate of gastric emp-
tying, which is now recognized to be of fundamental rele-
vance (Trahair et al. 2012). Gastric emptying varies
widely between individuals, but relatively little within an
individual, so that in health, nutrients such as glucose
usually empty from the stomach at an overall linear rate
between 1 and 4 kcal/min (Collins et al. 1983). Gastric
distension, even at modest volumes, increases sympathetic
activity – the so-called “gastrovascular reflex” (Rossi et al.
1998) – while intraduodenal administration of glucose,
which “bypasses” the stomach and avoids gastric disten-
sion, at rates (2–3 kcal/min) within the normal physiolo-
gical range increases plasma noradrenaline in healthy
young adults (Trahair et al. 2012). In young subjects,
intraduodenal infusion of glucose at 3 kcal/min is also
associated with an increase in HR but little, if any, change
in systolic BP (Trahair et al. 2012). In contrast, an identi-
cal glucose load in healthy older subjects reduces BP asso-
ciated with a decreased plasma noradrenaline response
(Trahair et al. 2012). More marked declines in BP occur
in patients with postprandial hypotension (a fall in sys-
tolic BP >20 mmHg, sustained for at least 30 min, occur-
ring within 2 h of a meal (Jansen and Lipsitz 1995)), an
increasingly recognized disorder associated with relatively
more rapid gastric emptying (Trahair et al. 2015).
Accordingly, in healthy older subjects and people with
postprandial hypotension, compensation for the postpran-
dial rise in splanchnic blood flow is inadequate (Trahair
et al. 2014).
These insights are of relevance to the interpretation of
postprandial BP and sympathetic responses in the obese.
In particular, gastric emptying has been reported to be
accelerated substantially in a subset of obese subjects
(Acosta et al. 2015), although observations have been
inconsistent (Seimon et al. 2013), and there is a wide
range of gastric emptying in the obese, as in healthy sub-
jects (Vazquez Roque et al. 2006; Park et al. 2007; Seimon
et al. 2013; Horner et al. 2015). Given that the rate of
intraduodenal glucose delivery affects catecholamine
responses in health (Trahair et al. 2012) variations in gas-
tric emptying may be of relevance to postprandial cate-
cholamine levels in the obese. There is, however, no
information about the effect of gastric emptying on
postprandial cardiovascular or noradrenaline responses in
obese subjects.
The aim of this study was to determine the effects of
intraduodenal glucose infusion at two rates within the
normal range of gastric emptying on BP, HR and nora-
drenaline responses in obese and healthy control subjects.
We hypothesized that HR and noradrenaline, but not BP,
responses are dependent on the intraduodenal glucose
load in both groups.
Materials and Methods
Subjects
Twelve obese subjects (2 female and 10 male, mean age
36.6  3.9 years (range: 21–56 years), body mass index
(BMI) 36.1  1.3 kg/m2 (range: 31.1–44.9 kg/m2)), and
23 healthy control subjects (7 female and 16 male, mean
age 27.8  2.4 years (range: 19–54 years), BMI 22.4 
0.5 kg/m2 (range: 19.0–25.0 kg/m2)), were recruited by
advertisement. Data in a subset of these subjects relating to
blood glucose, serum insulin, and incretin hormone
responses have been reported (Trahair et al. 2017). In all
obese subjects, an oral glucose tolerance test (75 g glucose)
was performed <6 weeks before the first intraduodenal
study to exclude diabetes. All subjects were nonsmokers
and none had a history of cardiovascular, hepatic, renal or
gastrointestinal disease, epilepsy or alcohol abuse. No sub-
ject was pregnant, breast feeding, or taking medication
known to influence BP or gastrointestinal function, and
any other medication was withheld for 24 h prior to each
study day.
Protocol
Subjects were studied on three occasions, separated by at
least 1 week. On each study day, the subject attended the
Discipline of Medicine at the Royal Adelaide Hospital at
0830 h, after an overnight fast. Upon arrival at the labo-
ratory, a silicone-rubber, multilumen nasoduodenal cathe-
ter (external diameter ~4 mm) (Dentsleeve International,
Mui Scientific, Mississauga, Canada) was inserted into the
stomach via an anesthetized nostril and allowed to pass
into the duodenum by peristalsis (Trahair et al. 2012).
The catheter was designed so that, once positioned, the
opening of an infusion channel (internal diameter
~1 mm) was located ~10 cm distal to the pylorus. Two
other channels, with openings located in the antrum
(2.5 cm proximal to the pylorus) and in the duodenum
(2.5 cm distal to the pylorus), were perfused continuously
with 0.9% saline (Trahair et al. 2012). The correct posi-
tioning of the catheter was maintained by continuous
measurement of the transmucosal potential difference
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(TMPD) from the antral (40 mV) and duodenal
(0 mV) channels. This was achieved using a 0.9% saline-
filled reference electrode (20-gauge intravenous (IV) can-
nula) that was inserted subcutaneously into the subject’s
forearm (Heddle et al. 1988; Trahair et al. 2012). After
the catheter was positioned correctly, the subject was
placed in a supine position and an IV cannula inserted
into a left antecubital vein for blood sampling. The sub-
ject then remained in the recumbent position and was
allowed to rest for 15–30 min.
Commencing at t = 0 min (~0930 h), each subject
received an intraduodenal infusion of glucose at either 1
or 3 kcal/min (“G1” or “G3”, respectively), or 0.9% saline
(“S”) for 60 min (t = 0–60 min), followed by saline for a
further 60 min (t = 60–120 min). The order of the infu-
sions on the three study days was randomized and studies
were performed in a double-blind fashion. All infusions
were performed, using an automated volumetric infusion
pump, at a rate of 5 mL/min (Imed Gemini PC-1: IMED
Corporation, San Diego, CA). At t = 120 min, the naso-
duodenal catheter and cannulae were removed and the
subject was offered a light meal prior to leaving the labo-
ratory. On one of the study days, autonomic nerve func-
tion was evaluated following lunch using standardized
cardiovascular reflex tests (Piha 1991).
The protocol was approved by the Research Ethics
Committee of the Royal Adelaide Hospital, and each sub-
ject provided written, informed consent. All experiments
were carried out in accordance with the Declaration of
Helsinki.
Measurements
Blood pressure and heart rate
BP and HR were measured using an automated oscillo-
metric BP monitor (DINAMAP ProCare 100, GE Medical
Systems, Milwaukee, WI), every 3 min during the rest per-
iod, and between t = 0–120 min. Baseline BP was calcu-
lated as an average of the three measurements obtained
immediately prior to commencement of infusion (i.e.,
t = 9, t = 6 and t = 3 min) (Trahair et al. 2012).
Plasma noradrenaline
Venous blood samples were collected immediately prior to
commencement of infusion (at t = 3 min) and then at
60 and 120 min for measurement of plasma noradrenaline
(Trahair et al. 2012). Blood samples were obtained in tubes
containing EDTA, centrifuged at 1490 g for 15 min and
plasma separated and stored at 70°C for subsequent anal-
ysis. Noradrenaline was measured, using high performance
liquid chromatography coupled with electrochemical
detection (Waters Corporation, Milford, MA) (Holmes
et al. 1994). The minimum detectable limit was 0.1 nmol/L
and the intra-assay coefficient of variation was 5.2%.
Autonomic nerve function
Autonomic nerve function was assessed using standard-
ized cardiovascular reflex tests (Piha 1991). Parasympa-
thetic function was evaluated by the variation (R-R
interval) of the heart rate during deep breathing and the
response to standing (“30:15” ratio). Sympathetic func-
tion was assessed by the fall in systolic BP in response to
standing. Each test result was scored according to age-
adjusted predefined criteria as 0 = normal, 1 = borderline
and 2 = abnormal for a total maximum score of 6. A
score ≥3 was considered to indicate autonomic dysfunc-
tion (Piha 1991).
Statistical analysis
Incremental areas under the curve (iAUCs) between
t = 0–60 min were calculated for all variables, using the
trapezoidal rule. For all variables, baseline values, iAUCs
and changes over time between t = 0–60 min (i.e., time
effect) were analyzed, using one-way repeated measures
ANOVA. Student’s unpaired t-test was used to compare
iAUCs between the obese and control subjects. All analy-
ses were performed, using SPSS 17.0.0 (SPSS Inc, Chi-
cago, IL). Data are presented as mean values  standard
error of the mean (SEM). A P value <0.05 was considered
significant.
Results
The studies were well tolerated, three subjects in the con-
trol group experienced mild symptoms consistent with
hypoglycemia which did not require intervention. Baseline
values are listed in Table 1. There was a trend for the
obese subjects to be older than the controls (P = 0.05).
None of the obese subjects had cardiovascular autonomic
neuropathy (score 1.8  0.3).
Systolic blood pressure
Controls
There was no difference in systolic BP at baseline
(P = 0.82), nor any change in systolic BP over time, dur-
ing any of the conditions (S: P = 0.74, G1: P = 0.82, G3:
P = 0.10) (Fig. 1A). There was no treatment effect on the
iAUCs between the conditions (P = 0.48).
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Obese
There was no difference in systolic BP at baseline
(P = 0.83), nor any change in systolic BP over time, dur-
ing any of the conditions (S: P = 0.27, G1: P = 0.94, G3:
P = 0.63) (Fig. 1B). There was no treatment effect on the
iAUCs between the conditions (P = 0.37).
Between-group comparisons
Baseline systolic BP was greater in the obese group on all
three study conditions (P < 0.05 for all). There was no
difference between the groups in the systolic BP response
during any of the conditions (S: P = 0.76, G1: P = 0.46,
G3: P = 0.32).
Diastolic blood pressure
Controls
There was no difference in diastolic BP at baseline between
the three conditions (P = 0.72). There was no change in
diastolic BP over time during S (P = 0.49), however, there
was a fall during both G1 (P < 0.01) and G3 (P < 0.001)
(Fig. 1C). There was a treatment effect on the iAUCs
between the conditions (P < 0.05), so that the iAUC for
G3 was less than S (P < 0.05) and G1 (P < 0.05), with no
difference between G1 and S (P = 1.00).
Obese
There was no difference in diastolic BP at baseline
between the three conditions (P = 0.27). There was no
change in diastolic BP over time during S (P = 0.72) or
G1 (P = 0.35), however, there was a fall during G3
(P < 0.01) (Fig. 1D). There was no treatment effect on
the iAUCs between the conditions (P = 0.24).
Between-group comparisons
Baseline diastolic BP was greater in the obese group on
all three study conditions (P < 0.05 for all). There was no
difference between the groups in the diastolic BP response
during any of the conditions (S: P = 0.62, G1: P = 0.08,
G3: P = 0.89).
Heart rate
Controls
There was no difference in HR at baseline between the
three conditions (P = 0.52). There was no change in HR
over time during S (P = 0.14) or G1 (P = 0.41), but there
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Figure 1. Systolic (A, B), diastolic (C, D) blood pressure (BP) and heart rate (E, F) responses to intraduodenal infusion of saline, or glucose at
1 kcal/min (G1) or 3 kcal/min (G3) between t = 0–60 min, followed by intraduodenal saline between t = 60–120 min, in healthy control (A, C,
E) (n = 23) or obese (B, D, F) (n = 12) subjects. In the control group there is a fall in diastolic BP during G1 (P < 0.01) and G3 (P < 0.001) and
a rise in heart rate during G3 (P < 0.001). In the obese subjects, there is a fall in diastolic BP (P < 0.01) and a rise in heart rate (P < 0.001)
during G3. Responses did not differ between the two groups.
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(P < 0.001) (Fig. 1E). There was a treatment effect on the
iAUCs between the conditions (P < 0.001), so that the
iAUC for G3 was greater than S (P < 0.001) and G1
(P < 0.001), with no difference between G1 and S
(P = 0.38).
Obese
There was no difference in HR at baseline between the
three conditions (P = 0.50). There was no change in HR
over time during S (P = 0.70) or G1 (P = 0.83), but there
was a sustained increase during G3 (P < 0.001) (Fig. 1F).
There was a treatment effect on the iAUCs between the
conditions (P < 0.001), so that the iAUC for G3 was
greater than S (P < 0.001) and G1 (P < 0.05), with no
difference between G1 and S (P = 0.10).
Between-group comparisons
There was no difference in HR between the groups, either
at baseline (P = 0.44), or in response to any of the condi-
tions (S: P = 0.33, G1: P = 0.72, G3: P = 0.20).
Plasma noradrenaline
Control
There was no difference in noradrenaline at baseline
between the three conditions (P = 0.94). There was no
change in noradrenaline during S (P = 0.41) or G1
(P = 0.33), but there was a rise during G3 (P < 0.01)
(Fig. 2A). There was a trend for a treatment effect on the
iAUCs between the conditions (P = 0.07).
Obese
There was no difference in noradrenaline at baseline
between the three conditions (P = 0.79). There was no
change in noradrenaline during S (P = 0.35) or G1
(P = 0.35), but there was a rise during G3 (P < 0.001)
(Fig. 2B). There was a treatment effect on the iAUCs
between the conditions (P < 0.05), with no individual
differences between S and G1 (P = 1.00), G3 (P = 0.21),
or between G1 and G3 (P = 0.11).
Between-group comparisons
There was no difference in noradrenaline between the
groups, either at baseline (P = 0.09), or in response to
any of the conditions (S: P = 0.71, G1: P = 0.56, G3:
P = 0.75).
Discussion
Our study has evaluated the effects of intraduodenal glu-
cose infusion at two rates within the physiological range
of gastric emptying on BP, HR and plasma noradrenaline
in obese adults and compared these responses to those in
healthy lean subjects. Novel observations are that (i) nei-
ther glucose load affected systolic BP in either group and
(ii) intraduodenal glucose at 3 kcal/min, but not at
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Figure 2. Plasma noradrenaline responses to intraduodenal infusion of saline, or glucose at 1 kcal/min (G1) or 3 kcal/min (G3) between
t = 0–60 min, followed by intraduodenal saline between t = 60–120 min, in healthy control (A) (n = 23) or obese (B) (n = 12) subjects. In both
groups, there was a rise in noradrenaline during G3 (P < 0.01) without any difference in the response between the two groups.
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decline in diastolic BP and increases in HR and plasma
noradrenaline in both groups. Predictably, baseline sys-
tolic and diastolic BP were slightly higher in the obese.
These observations suggest that in “younger” adult sub-
jects with and without obesity, postprandial BP and sym-
pathetic responses are dependent on the rate of gastric
emptying.
Studies of gastric emptying in obesity are numerous
given the relevance to appetite regulation and postpran-
dial glycaemic control (Vazquez Roque et al. 2006; Park
et al. 2007; Seimon et al. 2013; Horner et al. 2015). Gas-
tric emptying in the obese has been variously reported to
be faster (Vazquez Roque et al. 2006; Acosta et al. 2015;
Horner et al. 2015), slower (Horowitz et al. 1983), or
comparable (Park et al. 2007; Seimon et al. 2013) to
healthy subjects. Despite these inconsistencies, which may,
in part, reflect prior patterns of macronutrient intake, it
is clear that the inter-individual variation in gastric emp-
tying in the obese is large, as is the case in healthy sub-
jects, and that gastric emptying is accelerated substantially
in some (Acosta et al. 2015). To our knowledge, no stud-
ies have evaluated the sympathetic response to gastric dis-
tension in the obese; which is known to be diminished in
older subjects (van Orshoven et al. 2004). Our observa-
tions relating to the noradrenaline responses to intraduo-
denal glucose in the younger subjects are consistent with
our previous studies (Trahair et al. 2012). It is now clear
that these responses are also dependent on the duodenal
glucose load in the obese, as well as comparable between
the groups. We anticipated that there would be no fall in
systolic BP, and a rise in HR in response to the 3 kcal/
min duodenal glucose load in the healthy subjects (Tra-
hair et al. 2012), and this proved to be the case, with
comparable responses in the obese. In both groups, there
was a modest decline in diastolic BP. This is not unex-
pected as diastolic BP is dependent on peripheral vascular
resistance, while systolic BP is more dependent on pre-
load and contractility, both of which would be reduced
with inadequate increase in sympathetic output (Guyenet
2006).
Some limitations of our study should be appreciated.
Our study utilized a nonphysiological test “meal”, to
eliminate factors relating to gastric emptying. The number
of subjects was not large, but the observations appeared
clear-cut. While there was a wide range of subjects stud-
ied, and the obese subjects tended to be older than the
controls, the difference was only minor and is unlikely to
affect postprandial noradrenaline responses (Trahair et al.
2012). The obese subjects were not categorized according
to insulin resistance. Plasma noradrenaline was only
assessed at one time point after the intraduodenal glucose,
given the exploratory nature of the study, but the timing
is likely to represent maximal response given the study
design. Noradrenaline concentrations in the forearm cir-
culation are, of course, primarily an index of sympathetic
activity in the forearm musculature, but are generally
regarded as a useful measure of average sympathetic out-
put (Goldstein et al. 1983). Finally, we did not measure
the splanchnic or skeletal muscle blood flow responses.
In conclusion, the cardiovascular and sympathetic
responses to intraduodenal glucose infusion at two rates
within the normal range of gastric emptying are compara-
ble in obese subjects and healthy lean controls. Since the
responses were dependent on the rate of intraduodenal
glucose infusion, future studies investigating these effects
should take into account the rate of gastric emptying.
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